This study examined the effects of MFN2 catalytic activity and allostery on defective mitochondrial fusion and neural transport in relation to Charcot-Marie-Tooth disease type 2A, an incurable peripheral neuropathy brought on by MFN2 mutations. Here, MFN2 is linked to Charcot-Marie-Tooth disease type 2A1.